2011
DOI: 10.1111/j.1463-5224.2010.00858.x
|View full text |Cite
|
Sign up to set email alerts
|

Superficial corneal squamous cell carcinoma occurring in dogs with chronic keratitis

Abstract: Chronic inflammatory conditions of the cornea and topical immunosuppressive therapy may be risk factors for developing primary corneal SCC in dogs. SCC should be considered in any differential diagnosis of corneal proliferative lesions. Superficial keratectomy with complete excision is recommended, and the metastatic potential appears to be low.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
59
0
2

Year Published

2012
2012
2018
2018

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 55 publications
(65 citation statements)
references
References 39 publications
4
59
0
2
Order By: Relevance
“…Preexisting ocular disease and topical corticosteroids were also reported as potential risk factors in the development of canine keratomycosis, and treatment with cyclosporine is reported to increase the severity of murine Fusarium keratitis . Chronic superficial keratitis and topical cyclosporine or tacrolimus use are reported as risk factors in canine corneal squamous cell carcinoma …”
Section: Discussionmentioning
confidence: 99%
“…Preexisting ocular disease and topical corticosteroids were also reported as potential risk factors in the development of canine keratomycosis, and treatment with cyclosporine is reported to increase the severity of murine Fusarium keratitis . Chronic superficial keratitis and topical cyclosporine or tacrolimus use are reported as risk factors in canine corneal squamous cell carcinoma …”
Section: Discussionmentioning
confidence: 99%
“…Anecdotally, this drug can also halt progression of and even improve superficial corneal pigmentation in some dogs. This drug, as well as chronic keratitis, have been described as potential risk factors for corneal neoplasia development . In this report, we recommended use of tacrolimus to improve the corneal pigmentation present at initial examination 3 years prior to tumor development.…”
Section: Discussionmentioning
confidence: 95%
“…Due to the progression of corneal pigmentation, therapy with topical 2% cyclosporine was reinstituted. Despite the observation of decreased corneal pigmentation with topical 1% 5‐fluorouracil, the health and environmental concerns were deemed to be greater than the possible association of topical cyclosporine and corneal SCC. Additionally, the corneal SCC lesion noted in the present case was observed prior to any therapy with topical cyclosporine.…”
Section: Discussionmentioning
confidence: 99%
“…In dogs, however, these factors have not been demonstrated to influence the development of ocular SCC. Recently, chronic keratitis, as seen in brachycephalic breeds, and the use of topical cyclosporine have been hypothesized to play a role in the pathogenesis of corneal SCC in dogs . The primary treatment strategy in large animals has consisted of surgical excision of the affected tissue, and recurrence rate may be decreased with the use of adjunctive procedures such as cryotherapy, immunotherapy, radiofrequency hyperthermia, strontium 90 irradiation, or topical chemotherapy .…”
Section: Introductionmentioning
confidence: 99%